Bull, Bear, Scenarios

Bull, Bear, Scenarios

Figures converted from IDR at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

The report has now examined Avian through several lenses, and they do not resolve to a single answer. It is Indonesia's most profitable paint maker, carries essentially no debt, and trades near a third of its peers' earnings multiple, yet its growth has slowed, its margins are drifting, and nearly half its cost base runs through family-owned suppliers. Whether about 11x is a fallen-star bargain or a fair price for a mature compounder turns on a few measurable things. This chapter reconciles them and sets out what to watch.

Sources: FY2025 Annual Report, income statement and balance sheet [1] [2]; shareholder yield and target upside from reported returns and consensus estimates (mean 12-month target $0.028, 5 Buy).

The two readings, on shared facts

Both cases are built from the same numbers; they part on interpretation. The table below pairs each shared fact with the bull reading, the bear reading, and the evidence that would settle it. None of the rows is a matter of sentiment — each is a figure, a filing item, or a trend that a future report will confirm or refute.

Sources: FY2025 Annual Report — income statement [3], balance sheet [4], and related-party note [5]; Q1 2026 results [6]. Detail in Financials and Estimates, The Distribution Moat, Ownership and Affiliates and Valuation.

Two rows carry most of the weight. Row 1 is the price itself: at 10.9x on FY2025 earnings of $0.0017 per share, with almost all profit paid out, the multiple embeds only about 2-5% perpetual growth [7]. That is below the ~6.5% the company now projects for the industry through 2032 [8]. So the disagreement is not really about quality — both sides concede the margins — but about whether Avian can grow faster than the low bar its own price has set.

Row 6 is the near-term tell. Consensus models FY2026 EPS at $0.0017, slightly below FY2025, even though first-quarter revenue rose 16.8% and net profit 12.6% [9]. Margins explain the gap: Q1 gross margin slipped to 44.9% from 45.8% and finance income fell to $3.0 million from $4.0 million [10]. Strong top-line, thinner margin — the cautious forecast is a call on the second effect outrunning the first, not simple staleness.

Three scenarios

The scenarios below translate the debate into rough fair-value ranges. Each is anchored on FY2025 earnings of $0.0017 per share and the current price of about $0.017, and each is driven by two levers: how fast volume grows against the ~6.5% market, and whether the gross margin holds near 44%. The ranges are widest, and most sensitive, to the margin lever — a single point of gross margin is worth roughly $4.9 million of pre-tax profit on the FY2025 base [11].

Source: scenario ranges derived from FY2025 reported EPS of $0.0017 [12] and consensus FY2026-27 estimates; the current price is about $0.017 and the mean 12-month target is $0.028.

The correctly-repriced case holds EPS roughly flat, keeps the multiple at 9-11x, and lands near where the stock already trades — a mature paint maker earning a fair, unremarkable return. The base case assumes mid-single-digit volume in line with the market and a gross margin that steadies near 44%, supporting a modest re-rating to 12-14x. The fallen-star case, which the all-Buy consensus and its $0.028 target embody, needs volume to re-accelerate toward the pre-IPO growth expectation and the multiple to expand to 16-18x. Today's price sits at the top of the first band and the bottom of the second — precisely the fallen-star reader's attraction, provided the base case, not the bear case, is the true centre of gravity.

The case that the market has it right

Because this reader is drawn to fallen stars, the more disciplined exercise is to state the opposing case in full — that Avian is not mispriced but fairly priced, and the de-rating was the market correcting an error it made at the IPO, not making a new one now. That case is stronger than the raw "down two-thirds" headline suggests, and it rests on four facts already established in this report.

First, the IPO multiple was never a defensible anchor. It embedded a Frost and Sullivan forecast of ~9.8% annual market growth that never arrived; Avian's revenue instead compounded 4.6% a year in rupiah and close to flat in dollars, and the company has since cut its own forward industry assumption to ~6.5% [13]. A stock that falls from a price it should never have carried is not thereby cheap. Second, much of the discount to global peers is explained rather than anomalous: a 16% free float and thin liquidity, an Indonesian small-cap cost of equity well above a developed-market one, and — most concretely — a governance overhang in the cost base. Avian buys 44.7% of its cost of goods sold — $122 million in 2025, up from 36.2% in 2022 — from suppliers under the same family's control, a related-party dependence that offers a governance-discount explanation for why the shares trade at ~11x against a listed-peer median near 26x rather than the pure mispricing the cheapness case implies [14]. Third, the margin trend runs the wrong way, if gently: consolidated gross margin has eased to 44.0% and net margin to 21.5% from a 2023 peak, and the first quarter of 2026 extended the slide [15] [16]. Fourth, the reverse-Gordon math is not obviously generous: an implied ~2-5% perpetual growth is a reasonable price for a business that has actually delivered ~4.6% rupiah and roughly flat dollar earnings.

The counterweight is equally factual, and it is why the case does not close. The feature this reader prizes most — near-zero chance of permanent capital loss from leverage — is present in an unusually clean form: $253 million of cash and short-term investments against about $0.4 million of bank debt [17]. Whatever the growth outcome, bankruptcy is not the risk. And the same price that the bear calls fair already discounts a mature trajectory, so the business does not need to surprise to the upside to work; it only needs to avoid deteriorating. The correctly-repriced case, in short, is a good description of the downside and a poor description of the asymmetry. What separates the two readings is not quality or solvency but two measurable things: whether delivered volume grows toward the ~6.5% market or stalls below it, and the affiliate-COGS trend that sits alongside it.

What to watch

The watch list below is falsifiable: each item names the line, the filing it appears in, and the threshold that would move the read one way or the other. The nearest checkpoint is close — Avian's next results are due at the end of July 2026.

Sources: FY2025 Annual Report — income statement [18] and related-party note [19]; Q1 2026 results [20]; FY2026 guidance and Q1 snapshot [21]; next results date and payout ratio from company reporting and consensus estimates.

Two of these are leading indicators and worth the most attention. The selling-expense line is the earliest sign of moat pressure: for now Avian is holding share without a promotional blitz, with selling expense up 4.5% against revenue up 8.7% [22]. The day that reverses, the distribution moat is being defended with price rather than reach. And the related-party share of cost, already the report's central governance question, is the line most sensitive to whether the family's alignment stays genuine or turns extractive as the growth tailwind slows [23]. For a holder, the base case is the reasonable expectation and the net-cash balance sheet is the floor beneath it; the scenarios diverge from there on evidence that arrives, quarter by quarter, in exactly these lines.